TREVI THERAPEUTICS INC (TRVI) Institutional Shareholders

TREVI THERAPEUTICS INC (TRVI) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $2.74B in TRVI holdings during the latest filing period.

Nea Management Company, Llc is currently the largest disclosed institutional shareholder of TRVI tracked by InsiderSet, reporting ownership valued at approximately $246.59M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $197.67M, representing an estimated loss of -19.84% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 50% of the total disclosed TRVI value among the investors covered in this analysis. Major shareholders include Nea Management Company, Llc, Fmr Llc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in TREVI THERAPEUTICS INC (TRVI).

This page ranks the largest institutional TRVI shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

211

Total Reported Value

$2.74B

Largest Holder

Nea Management Company, Llc

Largest Position

$246.59M

Insider Transactions (90d)

5

Latest Filing Quarter

Q2 2026

New Institutional Positions

60

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Nea Management Company, Llc15.53%13,222,228$246,594,552$197,672,309-$48,922,243-19.84%
Fmr Llc0.01%12,562,839$234,296,949$187,814,443-$46,482,506-19.84%
Blackrock, Inc.0.00%11,155,026$208,041,234$166,767,639-$41,273,595-19.84%
Frazier Life Sciences Management, L.P.4.04%9,939,447$185,370,687$148,594,733-$36,775,954-19.84%
Wellington Management Group Llp0.02%5,684,592$106,017,642$84,984,650-$21,032,992-19.84%
Vanguard Capital Management Llc0.00%5,530,675$103,147,089$82,683,591-$20,463,498-19.84%
Vivo Capital, Llc8.68%5,094,668$95,015,558$76,165,287-$18,850,271-19.84%
Woodline Partners Lp0.24%4,081,333$76,116,860$61,015,928-$15,100,932-19.84%
Vestal Point Capital, Lp1.35%3,100,000$57,815,000$46,345,000-$11,470,000-19.84%
Mpm Bioimpact Llc3.50%3,073,577$57,322,211$45,949,976-$11,372,235-19.84%
Frontier Capital Management Co Llc0.53%3,070,740$57,269,301$45,907,563-$11,361,738-19.84%
State Street Corp0.00%3,027,315$56,459,425$45,258,359-$11,201,066-19.84%
Geode Capital Management, Llc0.00%2,928,068$54,619,528$43,774,617-$10,844,911-19.86%
Marshall Wace, Llp0.04%2,674,137$49,872,655$39,978,348-$9,894,307-19.84%
Eventide Asset Management, Llc0.66%2,660,000$49,609,000$39,767,000-$9,842,000-19.84%
Rubric Capital Management Lp0.43%2,504,513$46,709,167$37,442,469-$9,266,698-19.84%
Artia Global Partners Lp7.84%2,210,852$41,232,390$33,052,237-$8,180,153-19.84%
Acorn Capital Advisors, Llc10.92%2,144,844$40,001,341$32,065,418-$7,935,923-19.84%
First Light Asset Management, Llc2.38%2,097,215$39,113,060$31,353,364-$7,759,696-19.84%
Pictet Asset Management Holding Sa0.04%2,013,786$37,557,109$30,106,101-$7,451,008-19.84%
Logos Global Management Lp1.51%1,880,000$35,062,000$28,106,000-$6,956,000-19.84%
Affinity Asset Advisors, Llc1.64%1,800,172$33,573,208$26,912,571-$6,660,637-19.84%
Emerald Advisers, Llc0.79%1,797,611$33,525,445$26,874,284-$6,651,161-19.84%
Siren, L.L.C.0.68%1,786,867$33,325,070$26,713,662-$6,611,408-19.84%
Pivotal Bioventure Partners Investment Advisor Llc10.56%1,742,672$32,500,833$26,052,946-$6,447,887-19.84%
Raymond James Financial Inc0.01%1,610,657$30,038,753$24,079,322-$5,959,431-19.84%
Viking Global InvestorsOle Andreas Halvorsen0.08%1,544,644$28,807,611$23,092,428-$5,715,183-19.84%
Bank Of America Corp0.00%1,532,889$28,588,381$22,916,691-$5,671,690-19.84%
Assenagon Asset Management S.A.0.04%1,525,314$28,447,106$22,803,444-$5,643,662-19.84%
Alliancebernstein L.P.0.01%2,355,453$28,100,554$35,214,022+$7,113,468+25.31%
Orbimed Advisors Llc0.51%1,430,293$26,674,964$21,382,880-$5,292,084-19.84%
Jones Hill Capital Lp5.31%1,339,212$24,976,304$20,021,219-$4,955,085-19.84%
Nan Fung Trinity (Hk) Ltd2.23%1,213,620$22,634,013$18,143,619-$4,490,394-19.84%
Emerald Mutual Fund Advisers Trust0.79%1,210,965$22,584,497$18,103,927-$4,480,570-19.84%
Goldman Sachs Group Inc0.00%1,202,520$22,426,998$17,977,674-$4,449,324-19.84%
Soleus Capital Management, L.P.0.76%1,179,618$21,999,876$17,635,289-$4,364,587-19.84%
Vanguard Portfolio Management Llc0.00%1,176,872$21,948,663$17,594,236-$4,354,427-19.84%
Barclays Plc0.01%1,142,077$21,299,737$17,074,051-$4,225,686-19.84%
Saturn V Capital Management Lp2.81%1,052,043$19,620,602$15,728,043-$3,892,559-19.84%
Flputnam Investment Management Co0.23%1,038,057$19,359,763$15,518,952-$3,840,811-19.84%
Northern Trust Corp0.00%1,006,038$18,762,609$15,040,268-$3,722,341-19.84%
Charles Schwab Investment Management Inc0.00%965,402$18,004,747$14,432,760-$3,571,987-19.84%
Candriam S.C.A.0.08%966,219$18,002,647$14,444,974-$3,557,673-19.76%
Balyasny Asset Management L.P.0.03%845,087$15,760,873$12,634,051-$3,126,822-19.84%
Vanguard Fiduciary Trust Co0.00%841,059$15,685,750$12,573,832-$3,111,918-19.84%
Morgan Stanley0.00%800,465$14,928,673$11,966,952-$2,961,721-19.84%
Nuveen, Llc0.00%765,176$14,270,533$11,439,381-$2,831,152-19.84%
Burkehill Global Management, Lp0.49%725,000$13,521,250$10,838,750-$2,682,500-19.84%
Silverarc Capital Management, Llc1.41%678,095$12,646,472$10,137,520-$2,508,952-19.84%
Ameriprise Financial Inc0.00%622,381$11,607,406$9,304,596-$2,302,810-19.84%
Showing 50 of 211

Frequently asked questions about TRVI

  • Who owns the most TRVI stock?

    The largest holders of TRVI are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for TREVI THERAPEUTICS INC (TRVI).

  • Is TRVI widely held by superinvestors?

    Many widely followed stocks like TRVI appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly TRVI is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.